GORTEC (Groupe d'Oncologie Radiothérapie Tête Et Cou or Head and Neck Oncology and Radiotherapy Group) was created in 1999 by five founding centers (Clermont-Ferrand, Nancy, Nantes, Tours and Villejuif) with the aim of coordinating clinical and/or laboratory studies in the field of cervicofacial oncology. GORTEC studies are open to all centers wishing to participate. However, a quality control of the records of patients included in these trials is routinely performed by outside experts.

A few figures

• Multidisciplinary network of around 500 Investigators: Surgeons, Radiotherapists, Oncologists, Radiologists.
• Network of >+ than 100 cancer treatment centers in France, Switzerland, Belgium, Germany, Spain, Greece and Poland
• National and international clinical trials: Phase III (predominantly), Phase II & Phase I.
• Founding member of and driving force behind Intergroupe ORL (ENT intergoup), labeled by INCa (Institut National du Cancer or French National Cancer Institute) since 2012
• Over 225 members (Physicians)
• Approximately 40 employees
• Organization of biannual scientific meetings (Approximately 180 participants)